drugset / Trial / NCT01259050
Safety Study of High Doses of Zinc in ALS Patients
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety of Zinc given at 90mg/d in conjunction with 2mg/d of copper in ALS patients.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-01
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zinc Sulfate | Unknown | 90 mg | — |
| Background | copper | Other / unclassified | 1 mg | — |